UCLA scientists discover therapy that can suppress ulcerative colitis
24 July 2015 | By Victoria White
UCLA scientists have discovered a microRNA-214 inhibitor that has the ability to suppress the development of ulcerative colitis...
List view / Grid view
24 July 2015 | By Victoria White
UCLA scientists have discovered a microRNA-214 inhibitor that has the ability to suppress the development of ulcerative colitis...
2 July 2015 | By Victoria White
Scientists from The Scripps Research Institute have found that microRNAs plays surprisingly different roles in the formation of memory in animal models...
30 June 2015 | By Victoria White
Scientists have unravelled a key process in the bacterium that causes TB, potentially paving the way for new antibiotics to fight the disease...
10 June 2015 | By Victoria White
Researchers have discovered that certain microRNAs are also asymmetrically distributed within cells and may contribute as cell fate determinants...
20 April 2015 | By Victoria White
Takeda, Keio University and Niigata University are to collaborate to research disease-related RNA-binding proteins, possibly leading to new treatments...
24 March 2015 | By Victoria White
Rigontec, a company developing RNA-based immunotherapeutics, today announces it has raised €4.8 million in a second closing of its Series A financing round...
5 August 2014 | By Roche
Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark...
Developments over the past decade have demonstrated that non-coding RNAs can exert control of transcriptional gene expression. Recent advances in genome-wide studies have revealed an abundance of long non-coding RNAs (lncRNAs) in human cells, which are as numerous as protein-coding genes...
7 May 2014 | By Kevin V. Morris, Bhupinder Bhullar
In this Genomics In-Depth Focus: Kevin V. Morris discusses the therapeutic potential of RNA directed epigenetic regulation of transcription, and Bhupinder Bhullar looks at drug resistance mechanisms and target selection in disease treatment strategies...